The World Health Organization published new guidelines for managing HIV drug resistance in countries in which pretreatment HIV drug resistance to non-nucleoside reverse transcriptase inhibitors (NNRTIs) is prevalent.
Widespread discrimination in healthcare has taken many forms, and violates the most fundamental of human rights. WHO established a goal "to ensure that none is left behind and to read the furthest behind first."
WHO has updated its Essential Medicines List to include new recommendations on which antibiotics to use for common infections and serious conditions.
Clinical Pain Advisor Articles
- Chronic Pain May Be a Contributing Factor to Suicide
- Striking a Balance Between Opioid Surveillance and Patient Privacy
- Demographic Characteristics of Pregnant Women With Opioid Use Disorder
- Effects of Mindfulness Therapy, Pharmacologic Prophylaxis on Catecholamine Levels in Migraine
- Supervised Injection Sites: Facts, Information, Pros, and Cons
- Perioperative Pain Management in Patients With Opioid Use Disorder
- Cannabinoid-Associated Analgesia May Be Mediated Through Modulation of Affective Processes
- Antidepressant Effects of Ketamine Appear to Require Opioid System Activation
- Reviewing the Efficacy of Intrathecal Morphine, Ziconotide for Cancer- and Noncancer Chronic Pain
- Seven-Item Pain Intensity Measure Reliable in Individuals With Dementia
- Factors Associated With Suboptimal Interscalene Brachial Plexus Block for Arthroscopy
- Initial Consultation for Neck Pain May Reduce Opioid Consumption, Healthcare Utilization
- Scholarship Support Limited for Veterans Enrolling in MD Programs
- Alpha and Beta Band Activity in MS-Related Chronic Pain
- New Opioid-Induced Constipation Management Guidelines Available